Direct Detection of Pulmonary Fibrosis by Near-Infrared-Responsive Biomimetic Platelets
Guanlie Li,Haiqing He,Guodong Zheng,Wenjing Jiang,Shuwen Du,Hua Tao,Tao Xiao,Dazhi Zhou,Shangwei Ding,Xi-Yong Yu,Yu Zhang,Ao Shen
DOI: https://doi.org/10.2147/IJN.S334331
IF: 7.033
2022-01-11
International Journal of Nanomedicine
Abstract:Guanlie Li, 1, &ast Haiqing He, 1, &ast Guodong Zheng, 1, &ast Wenjing Jiang, 1 Shuwen Du, 1 Hua Tao, 1 Tao Xiao, 1 Dazhi Zhou, 2 Shangwei Ding, 2 Xi-Yong Yu, 1 Yu Zhang, 1 Ao Shen 1 1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China; 2 Department of Ultrasound, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ao Shen; Yu Zhang Tel +86 20 3110 0902 ; +86 20 3710 3275 Email ; Background: Pulmonary fibrosis (PF) is a fatal lung disease and affects over 5 million patients worldwide. Precise and early detection of PF is of pivotal importance to slow the disease progression. However, there are currently no effective tools to detect PF directly. Purpose: This study aimed to develop an imaging modality to detect PF directly. Excessive collagen deposition is the hallmark of PF. Herein, we developed a novel PF diagnostic agent, namely PVD (platelets-derived nanovesicles labeled with dye), by utilizing near-infrared (NIR)-responsive biomimetic platelets that specifically recognize collagen. Methods: In brief, platelets membrane was extracted from purified platelets by freeze/thaw and formed to PVD nanovesicles via sonication and extrusion, when loaded with DiR dye. Red blood cells membrane loaded with DiR was prepared in the same way as PVD to form RVD as control. Collagen self-assembled on microplates was used as an in vitro collagen fibrils model and monocrotaline-induced rats were used as an in vivo PF model. Results: We demonstrated that PVD, but not RVD nor other controls, could bind collagen both in vitro and in vivo, and directly detect pulmonary fibrosis in vivo and ex vivo at the early PF stage. Conclusion: Collectively, PVD is a versatile NIR-responsive probe for the direct visualization of collagen, and can be particularly helpful in direct detecting PF. To the best of our knowledge, PVD is the first report of a NIR probe for the direct detection of pulmonary fibrosis. Keywords: pulmonary fibrosis, collagen, platelets, imaging diagnosis, near-infrared Affecting more than 5 million people globally, pulmonary fibrosis (PF) is a fatal lung disease with a prognosis of 50% mortality in 3–5 years after diagnosis. 1,2 PF is characterized by extensive scarring of the lung over time, due to excess deposition of collagen in the extracellular matrix, malfunctions of pulmonary cells, and loss of normal lung architecture. These changes lead to poor lung function and ultimately, respiratory failure. 1 Most of the time, PF occurs without an obvious cause. In this case, it is termed idiopathic pulmonary fibrosis (IPF). 2 PF is progressive and currently there is no cure for it. The main aim of medications and therapies for PF is to relieve symptoms and slow down progression. 3 Thus, the earlier PF could be detected, the better prognosis would be achieved by slowing the course of the disease. Unfortunately, the diagnosis of PF is mainly based on the patient's medical history, symptoms, lung function tests and medical imaging through either chest X-ray or computed tomography (CT), all of which provide indirect evidence. 2 Because the typical symptoms and imageology features of PF (eg, shortness of breath, dry cough, fatigue and inflammation) are too similar to other respiratory diseases (eg, the common cold, pneumonia or pulmonary embolism), the road to PF diagnosis is long and difficult, sometimes ends with misdiagnosis. 2,4,5 At present, lung biopsy is the only way to provide direct and solid evidence to diagnose patients with PF. However, such an invasive procedure prevents lung biopsy from being used regularly, especially at PF's early stage. Consequently, developing new detection methods is critically important to the precise and early diagnosis of PF. Excessive collagen accumulation is the hallmark of fibrotic diseases and incites pathological changes during PF. 1,2 Collagen thus becomes an ideal biomarker of PF and a promising target for diagnosis purpose. Although X-ray and CT can visualize the end results of collagen deposition (eg, reticular opacities and honeycombing), the direct visualization of collagen still requires lung biopsy histopathology. A handful of collagen-targeting probes have been developed for imaging assessment of fibrosis. 6–9 However, certain limitat -Abstract Truncated-